Risk factors for glucose intolerance in active acromegaly

被引:68
作者
Kreze, A [1 ]
Kreze-Spirova, E
Mikulecky, M
机构
[1] Inst Endocrinol, SK-03491 Lubochna, Slovakia
[2] Inst Prevent & Clin Med, Bratislava, Slovakia
关键词
acromegaly; diabetes mellitus; impaired glucose tolerance; impaired fasting glycemia; risk factors; inferential statistics;
D O I
10.1590/S0100-879X2001001100009
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In the present retrospective study we determined the frequency of glucose intolerance in active untreated acromegaly, and searched for risk factors possibly supporting the emergence of the diabetic condition. Among 43 patients, 8 (19%; 95% CI: 8-33%) had diabetes mellitus and 2 (5%; 1-16%) impaired glucose tolerance. No impaired fasting glycemia was demonstrable. The frequency of diabetes was on average 4.5 times higher than in the general Slovak population. Ten factors suspected to support progression to glucose intolerance were studied by comparing the frequency of glucose intolerance between patients with present and absent risk factors. A family history of diabetes and arterial hypertension proved to have a significant promoting effect (P <0.05, chi-square test). A significant association with female gender was demonstrated only after pooling our data with literature data. Concomitant prolactin hypersecretion had a nonsignificant promoting effect. In conclusion, the association of active untreated acromegaly with each of the three categories of glucose intolerance (including impaired fasting glycemia, not yet studied in this connection) was defined as a confidence interval, thus permitting a sound comparison with the findings of future studies. Besides a family history of diabetes, female gender and arterial hypertension were defined as additional, not yet described risk factors.
引用
收藏
页码:1429 / 1433
页数:5
相关论文
共 22 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]  
*AM DIAB ASS, 1997, DIABETES CARE, V20, P549
[4]  
[Anonymous], 1999, Diabetologia, V42, P647
[5]  
[Anonymous], INT TXB DIABETES MEL
[6]   EFFECTS OF TREATMENT WITH OCTREOTIDE IN ACROMEGALIC PATIENTS - A MULTICENTER ITALIAN STUDY [J].
AROSIO, M ;
MACCHELLI, S ;
ROSSI, CM ;
CASATI, G ;
BIELLA, O ;
FAGLIA, G ;
MARTINO, E ;
SQUATRITO, S ;
GIUSTI, M ;
CANNAVO, S ;
VELARDO, A ;
SICOLO, N ;
BARBARINO, A ;
TAMBURRANO, G ;
CICCARELLI, E .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 133 (04) :430-439
[7]  
Arya K R, 1997, J Indian Med Assoc, V95, P546
[8]   Prevalence of diabetes in acromegaly and Cushing's disease [J].
Biering, H ;
Knappe, G ;
Gerl, H ;
Lochs, H .
ACTA MEDICA AUSTRIACA, 2000, 27 (01) :27-31
[9]  
DIEM K, 1982, GELGY SCI TABLES, V2, P104
[10]   DIABETES IN ASSOCIATION WITH OTHER ENDOCRINE DISORDERS [J].
EMMER, M ;
GORDEN, P ;
ROTH, J .
MEDICAL CLINICS OF NORTH AMERICA, 1971, 55 (04) :1057-+